Overmedication

(Redirected from Overprescription)

Overmedication describes the excessive use of over-the-counter or prescription medicines for a person. Overmedication can have harmful effects, such as non-adherence or interactions with multiple prescription drugs.

Over-the-counter medication overuse

edit

Over-the-counter (OTC) medications are generally first-line therapies that people may choose to treat common acute illnesses, such as fevers, colds, allergies, headaches, or other pain. Many of these medications can be bought in retail pharmacies or grocery stores without a prescription. OTC medication overuse is most prevalent in adolescents and young adults.[1] This overuse is common due to the relatively low cost, widespread availability, low perceived dangers, and internet culture associated with OTC medications.[2] OTC medications may be combination formulations that contain multiple drugs. These combination formulations are often used with other substances, which complicates treatment for these types of overdoses. Furthermore, the easy access to information online can sometimes lead to self-diagnosis and self-medication, contributing to the potential for misuse and overuse.

Acetaminophen

edit

Overuse of acetaminophen is the leading cause of liver failure in the Western world.[3] The maximum daily limit of acetaminophen is 4 grams per day for someone with a healthy liver. It is also highly recommended to not go over the maximum daily limit. Exceeding the maximum daily limit could involve severe liver toxicity, liver failure, kidney failure, or even death.[4] People who have poor liver function or with chronic alcohol use disorder should either limit or not ingest acetaminophen to prevent morbidities.[5] Additionally, acetaminophen is an ingredient in many combination medications, increasing the risk of unintentional overdose. Consumers should read labels carefully and consult healthcare providers to ensure they are not consuming excessive doses. In cases of suspected overdose, immediate medical attention is needed to mitigate potential life-threatening consequences.[4]

Codeine

edit

Codeine is an opioid and shares similarities to other opioid overuse. Many OTC medications for cough have formulations that contain codeine, which people may seek to overuse. The common effects of codeine include miosis, respiratory depression, CNS depression, and decreased bowel motility.[6] Despite the risk of death, dependence is another significant issue related to codeine overuse. Tolerance can cause users to use more opioid, leading to dependence, especially with chronic daily use of codeine.[1] Additionally, the misuse of codeine-containing cough syrups has become a public health concern, as it can serve as a gateway to stronger opioids.[citation needed] Education about the risks and signs of opioid addiction can play a role in prevention and early intervention.

Dextromethorphan

edit

Dextromethorphan, also shortened to DXM, affects the NMDA receptor and serotonin receptors which is believed to give its psychoactive effects at high doses. Similarly to codeine, DXM comes primarily in formulations that contain other OTC medications and is not common to find DXM on its own. Moreso, people who use DXM tend to use it concomitantly with other substances such as alcohol, hallucinogens, sedative drugs, and opioids.[1] DXM has dose dependent psychoactive effects with lower dose leading to more restlessness and euphoria and higher doses causing hallucinations, delusional beliefs, paranoia, perceptual distortions, ataxia, and out of body experiences.[1]

Diphenhydramine

edit

Diphenhydramine is typically used for allergy relief, although it may be used to alleviate sleeping problems, anxiety, and overall restlessness.[7] Effects may include euphoria, hallucinations, or psychosis.[7] The anticholinergic activity of diphenhydramine may lead to tachycardia, dry mouth, blurred vision, mydriasis, depression, and urinary retention.[7]

In 2020, purposeful overmedication with Benadryl (diphenhydramine) was a concern due to use of social media by teenagers in the United States, with the FDA issuing a public warning about the possibility of seizures, hallucinations, breathing difficulty or loss of consciousness.[8]

Pseudoephedrine

edit

Pseudoephedrine, ephedrine or phenylpropanolamine can be overused with the intent for weight loss or improving athletic performance, possibly causing insomnia, diminished sense of fatigue, euphoria, and psychotic behavior.[1] The habitual use of the medication has led to dependence, with symptoms of restlessness, dysphoria, and distorted perceptions on withdrawal.[1]

Elderly

edit

Seniors (65 years old and up) are possible users of overmedication.[9] Seniors are disproportionately affected by not only adverse drug events, but also drug interactions and more hospital admissions.[medical citation needed]

The term for individuals taking five or more medications is polypharmacy, which commonly occurs in elderly people, increasing their risk of overmedication.[10] Medical providers are generally hesitant to prescribe polypharmacy in the elderly due to the risk of harmful drug interactions. Concerns with polypharmacy and elderly groups are reduced medication adherence, increased fall risk, cognitive function impairment, and adverse drug reaction.[11] Almost 75% of clinic visits result in people obtaining a written prescription.[12][13]

More careful prescribing practices could increase medication adherence in elderly people.[14][15] Single-pill combination formulations make it easier for a person to monitor medications.[15]

Overprescription

edit

Opioids

edit

Opioids are used for pain management acutely or prescribed after a surgical procedure. While opioids aid in short- and long-term pain management, overprescription or constant opioid-exposure increases the risk for addiction.[16] There is a rise within healthcare systems to manage prescription of opioids.[16] Children prescribed opioids may become susceptible to the harms of addiction.[17][18]

Reducing or withdrawing prescribed opioids, such as for people with chronic non-cancerous pain, using either dose-reduction or stopping opioid prescriptions, may be effective, but standards are absent for managing withdrawal symptoms and deprescribing coprescription of sedatives.[19][20] Studies found a significant increase in opioid surplus disposal when individuals were provided with the necessary education or disposal kits.[21][22]

Antibiotics

edit

As antibiotics inhibit bacterial infections, they are a commonly prescribed medication. Overuse of these medications over the years has contributed to reduced efficacy against certain bacteria due to antimicrobial resistance,[23] a global medical concern.[24] Antibiotic overprescription is a potential problem in acute care, primary hospitals, and dental offices.[24]

Antibiotic-resistant bacterial infections are increasing.[23] A systemic review of admitted COVID-19 patients who were prescribed antibiotics showed that 80% of the admitted people were given antibiotics upon admission without confirmed bacterial coinfections.[25]

Physicians prescribe antibiotics for non-indicated diagnoses, such as viral infections, possibly cntributing to more antibiotic-resistant infections, greater adverse drug events, more drug-drug interactions, and deaths.[26] Dentists may prescribe antibiotics for non-indicated conditions that could otherwise be treated with other interventions, according to clinical guidelines.[27]

References

edit
  1. ^ a b c d e f Schifano F, Chiappini S, Miuli A, Mosca A, Santovito MC, Corkery JM, et al. (2021-05-07). "Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants". Frontiers in Psychiatry. 12: 657397. doi:10.3389/fpsyt.2021.657397. PMC 8138162. PMID 34025478.
  2. ^ Chiappini S, Schifano F (2020-10-14). "What about "Pharming"? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs". Brain Sciences. 10 (10): 736. doi:10.3390/brainsci10100736. ISSN 2076-3425. PMC 7602178. PMID 33066476.
  3. ^ Bernal W, Hyyrylainen A, Gera A, Audimoolam VK, McPhail MJ, Auzinger G, et al. (July 2013). "Lessons from look-back in acute liver failure? A single centre experience of 3300 patients". Journal of Hepatology. 59 (1): 74–80. doi:10.1016/j.jhep.2013.02.010. PMID 23439263.
  4. ^ a b Chiew AL, Gluud C, Brok J, Buckley NA, et al. (Cochrane Hepato-Biliary Group) (February 2018). "Interventions for paracetamol (acetaminophen) overdose". The Cochrane Database of Systematic Reviews. 2018 (2): CD003328. doi:10.1002/14651858.CD003328.pub3. PMC 6491303. PMID 29473717.
  5. ^ Buckley NA, Whyte IM, O'Connell DL, Dawson AH (January 1999). "Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose". Journal of Toxicology. Clinical Toxicology. 37 (6): 753–757. doi:10.1081/clt-100102452. PMID 10584587.
  6. ^ Lavonas EJ, Dezfulian C (October 2020). "Impact of the Opioid Epidemic". Critical Care Clinics. 36 (4): 753–769. doi:10.1016/j.ccc.2020.07.006. PMID 32892827.
  7. ^ a b c "Diphenhydramine". Drugs.com. 29 February 2024. Retrieved 7 August 2024.
  8. ^ "FDA warns about serious problems with high doses of the allergy medicine diphenhydramine (Benadryl)". US Food and Drug Administration. 1 October 2020. Retrieved 7 August 2024.
  9. ^ Safer D (2019). "Overprescribed Medications for US Adults: Four Major Examples". Journal of Clinical Medicine Research. 11 (9): 617–622. doi:10.14740/jocmr3906. PMC 6731049. PMID 31523334.
  10. ^ Golchin N (2015). "Polypharmacy in the elderly". Journal of Research in Pharmacy Practice. 4 (2): 85–88. doi:10.4103/2279-042X.155755. PMC 4418141. PMID 25984546.
  11. ^ Davies LE, Spiers G, Kingston A, Todd A, Adamson J, Hanratty B (February 2020). "Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews". Journal of the American Medical Directors Association. 21 (2): 181–187. doi:10.1016/j.jamda.2019.10.022. ISSN 1538-9375. PMID 31926797.
  12. ^ Fulton MM, Allen ER (April 2005). "Polypharmacy in the elderly: a literature review". Journal of the American Academy of Nurse Practitioners. 17 (4): 123–132. doi:10.1111/j.1041-2972.2005.0020.x. ISSN 1041-2972. PMID 15819637.
  13. ^ Zurakowski T (2009). "The practicalities and pitfalls of polypharmacy". The Nurse Practitioner. 34 (4): 36–41. doi:10.1097/01.NPR.0000348320.38365.59. PMID 20075801.
  14. ^ Little M (2016). "The Burden of Overmedication: What Are the Real Issues?". The Journal of Post-Acute and Long-Term Care Medicine. 17 (2): 97–98. doi:10.1016/j.jamda.2015.12.001. PMID 26822559.
  15. ^ a b Munger MA (November 2010). "Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus". Drugs & Aging. 27 (11): 871–83. doi:10.2165/11538650-000000000-00000. PMID 20964461.
  16. ^ a b Stoicea N, Costa A, Periel L, Uribe A, Weaver T, Bergese SD (May 2019). "Current perspectives on the opioid crisis in the US healthcare system: A comprehensive literature review". Medicine. 98 (20): e15425. doi:10.1097/MD.0000000000015425. PMC 6531094. PMID 31096439.
  17. ^ Money NM, Schroeder AR, Quinonez RA, Ho T, Marin JR, Morgan DJ, et al. (2020-04-01). "2019 Update on Pediatric Medical Overuse: A Systematic Review". JAMA Pediatrics. 174 (4): 375–382. doi:10.1001/jamapediatrics.2019.5849. ISSN 2168-6211. PMID 32011675.
  18. ^ Emdin A, Strzelecki M, Seto W, Feinstein J, Bogler O, Cohen E, et al. (2021-12-01). "Medications Reconciled at Discharge Versus Admission Among Inpatients at a Children's Hospital". Hospital Pediatrics: hpeds.2021–006080. doi:10.1542/hpeds.2021-006080. ISSN 2154-1671. PMC 9156657. PMID 34807980.
  19. ^ Hamilton M, Kwok WS, Hsu A, Mathieson S, Gnjidic D, Deyo R, et al. (2023-03-01). "Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines". Pain. 164 (3): 485–493. doi:10.1097/j.pain.0000000000002746. ISSN 1872-6623. PMID 36001299.
  20. ^ Punwasi R, de Kleijn L, Rijkels-Otters JB, Veen M, Chiarotto A, Koes B (2022-02-01). "General practitioners' attitudes towards opioids for non-cancer pain: a qualitative systematic review". BMJ Open. 12 (2): e054945. doi:10.1136/bmjopen-2021-054945. ISSN 2044-6055. PMC 8808445. PMID 35105588.
  21. ^ Huynh MN, Yuan M, Gallo L, Olaiya OR, Barkho J, McRae M (2023-03-23). "Opioid Consumption After Upper Extremity Surgery: A Systematic Review". Hand. 19 (6): 1002–1011. doi:10.1177/15589447231160211. ISSN 1558-9455. PMC 11342701. PMID 36960481.
  22. ^ Lamplot JD, Premkumar A, James EW, Lawton CD, Pearle AD (July 2021). "Postoperative Disposal of Unused Opioids: A Systematic Review". HSS Journal. 17 (2): 235–243. doi:10.1177/15563316211001366. ISSN 1556-3316. PMC 8361585. PMID 34421437.
  23. ^ a b Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. (2016-01-09). "Understanding the mechanisms and drivers of antimicrobial resistance". The Lancet. 387 (10014): 176–187. doi:10.1016/S0140-6736(15)00473-0. hdl:10044/1/32225. ISSN 0140-6736. PMID 26603922.
  24. ^ a b Bassetti S (May 2022). "Optimizing antibiotic therapies to reduce the risk of bacterial resistance". European Journal of Internal Medicine. 99: 9–12. doi:10.1016/j.ejim.2022.01.029. PMID 35074246.
  25. ^ Rabbi F, Banfield L, Munir M, Chagla Z, Mayhew A, de Souza RJ (2023-10-01). "Overprescription of antibiotics for treating hospitalized COVID-19 patients: A systematic review & meta-analysis". Heliyon. 9 (10): e20563. Bibcode:2023Heliy...920563R. doi:10.1016/j.heliyon.2023.e20563. ISSN 2405-8440. PMC 10590847. PMID 37876436.
  26. ^ Rowe TA, Linder JA (2019-07-03). "Novel approaches to decrease inappropriate ambulatory antibiotic use". Expert Review of Anti-infective Therapy. 17 (7): 511–521. doi:10.1080/14787210.2019.1635455. ISSN 1478-7210. PMID 31232615.
  27. ^ Dana R, Azarpazhooh A, Laghapour N, Suda KJ, Okunseri C (2018-04-01). "Role of Dentists in Prescribing Opioid Analgesics and Antibiotics: An Overview". Dental Clinics of North America. Dental Public Health. 62 (2): 279–294. doi:10.1016/j.cden.2017.11.007. ISSN 0011-8532. PMID 29478458.